Skip to main content
Clinical Trials/NCT02748668
NCT02748668
Terminated
Not Applicable

Extracorporeal Membrane Oxygenation: Blood Cells

Spectrum Health Hospitals1 site in 1 country371 target enrollmentJanuary 20, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Extracorporeal Membrane Oxygenation
Sponsor
Spectrum Health Hospitals
Enrollment
371
Locations
1
Primary Endpoint
All cause mortality
Status
Terminated
Last Updated
last year

Overview

Brief Summary

The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.

Registry
clinicaltrials.gov
Start Date
January 20, 2015
End Date
August 23, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Renzo Loyaga Rendon

Medical Director of Cardiovascular Research

Spectrum Health Hospitals

Eligibility Criteria

Inclusion Criteria

  • Greater than or equal to 18 years of age
  • Subject presents to the CTICU at Butterworth Campus, Spectrum Health and is critically ill in the ICU needing ECMO therapy.

Exclusion Criteria

  • Subject is less than 18 years of age
  • Known prisoner
  • Control Subjects:
  • Inclusion Criteria
  • Greater than 18 years of age
  • Without any known cardiovascular, lung, or autoimmune disease.
  • Exclusion Criteria:
  • Less than or equal to 18 years of age
  • Known cardiovascular, lung, or autoimmune disease

Outcomes

Primary Outcomes

All cause mortality

Time Frame: 1 year

Study Sites (1)

Loading locations...

Similar Trials